BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20932148)

  • 21. How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease.
    Shale M; Ghosh S
    Gut; 2009 Sep; 58(9):1291-9. PubMed ID: 19671557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition.
    Willemsen LE; Hoetjes JP; van Deventer SJ; van Tol EA
    Clin Exp Immunol; 2005 Nov; 142(2):275-84. PubMed ID: 16232214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unravelling the pathogenesis of inflammatory bowel disease.
    Xavier RJ; Podolsky DK
    Nature; 2007 Jul; 448(7152):427-34. PubMed ID: 17653185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.
    Hörmannsperger G; Haller D
    Int J Med Microbiol; 2010 Jan; 300(1):63-73. PubMed ID: 19828372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding why probiotic therapies can be effective in treating IBD.
    Fedorak RN
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.
    Mankertz J; Schulzke JD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):379-83. PubMed ID: 17545772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-associated protein ZO-1 via VIPergic pathways.
    Neunlist M; Toumi F; Oreschkova T; Denis M; Leborgne J; Laboisse CL; Galmiche JP; Jarry A
    Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1028-36. PubMed ID: 12881224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration.
    Cesaro A; Brest P; Hofman V; Hébuterne X; Wildman S; Ferrua B; Marchetti S; Doglio A; Vouret-Craviari V; Galland F; Naquet P; Mograbi B; Unwin R; Hofman P
    Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G32-42. PubMed ID: 20185692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma.
    Dotan I; Allez M; Nakazawa A; Brimnes J; Schulder-Katz M; Mayer L
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1630-40. PubMed ID: 17347451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
    Sartor RB
    Am J Gastroenterol; 1997 Dec; 92(12 Suppl):5S-11S. PubMed ID: 9395346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of bacteria on the enteric nervous system: implications for the irritable bowel syndrome.
    Wood JD
    J Clin Gastroenterol; 2007; 41 Suppl 1():S7-19. PubMed ID: 17438418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation.
    Shkoda A; Ruiz PA; Daniel H; Kim SC; Rogler G; Sartor RB; Haller D
    Gastroenterology; 2007 Jan; 132(1):190-207. PubMed ID: 17241871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroimmunology of the gut: physiology, pathology, and pharmacology.
    Ben-Horin S; Chowers Y
    Curr Opin Pharmacol; 2008 Aug; 8(4):490-5. PubMed ID: 18675937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "For whom the bell tolls!" -- innate defense mechanisms and survival strategies of the intestinal epithelium against lumenal pathogens.
    Cario E; Gerken G; Podolsky DK
    Z Gastroenterol; 2002 Dec; 40(12):983-90. PubMed ID: 12518264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review article: the aetiopathogenesis of inflammatory bowel disease--immunology and repair mechanisms.
    Dignass AU; Baumgart DC; Sturm A
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():9-17. PubMed ID: 15352888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Alterations of intestinal epithelial barrier and flora in the irritable bowel syndrome].
    Piche T
    Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S40-7. PubMed ID: 19303538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasticity of the enteric nervous system during intestinal inflammation.
    Lomax AE; Fernández E; Sharkey KA
    Neurogastroenterol Motil; 2005 Feb; 17(1):4-15. PubMed ID: 15670258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate immunity in inflammatory bowel disease: state of the art.
    Hisamatsu T; Ogata H; Hibi T
    Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.